Published in Clin Exp Immunol on June 01, 1991
Protection of the intestinal mucosa by intraepithelial gamma delta T cells. Proc Natl Acad Sci U S A (2002) 2.69
Local and systemic immune responses in murine Helicobacter felis active chronic gastritis. Infect Immun (1993) 1.90
Characterisation of mucosal lymphoid aggregates in ulcerative colitis: immune cell phenotype and TcR-gammadelta expression. Gut (2000) 1.60
Intraepithelial lymphocytes in celiac disease immunopathology. Semin Immunopathol (2012) 1.41
Gastric T lymphocyte responses to Helicobacter pylori in patients with H pylori colonisation. Gut (1994) 1.40
Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin. J Exp Med (1996) 1.36
Humoral and cellular immune recognition of Helicobacter pylori proteins are not concordant. Clin Exp Immunol (1994) 1.11
Changes in human mucosal gamma delta T cell repertoire and function associated with the disease process in inflammatory bowel disease. Mol Med (1997) 1.04
Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development. Gut (1999) 0.96
Analysis of gamma delta V region usage in normal and diseased human intestinal biopsies and peripheral blood by polymerase chain reaction (PCR) and flow cytometry. Clin Exp Immunol (1995) 0.94
Persistent changes in circulating and intestinal γδ T cell subsets, invariant natural killer T cells and mucosal-associated invariant T cells in children and adults with coeliac disease. PLoS One (2013) 0.92
Immune responses to Helicobacter pylori infection. World J Gastroenterol (2014) 0.90
Changing jejunal gamma delta T cell receptor (TCR)-bearing intraepithelial lymphocyte density in coeliac disease. Clin Exp Immunol (1999) 0.88
Localization of T cell receptor (TCR)-gamma delta + T cells into human colorectal cancer: flow cytometric analysis of TCR-gamma delta expression in tumour-infiltrating lymphocytes. Clin Exp Immunol (1995) 0.88
Helicobacter pylori gastritis in cats with long-term natural infection as a model of human disease. Am J Pathol (2000) 0.85
T-cell, antibody, and cytokine responses to homologs of the 60-kilodalton heat shock protein in Helicobacter pylori infection. Clin Diagn Lab Immunol (1997) 0.84
Analysis of the cellular basis of keratinocyte growth factor overexpression in inflammatory bowel disease. Gut (1999) 0.84
Chemokine receptor 5 expression in gastric mucosa of Helicobacter pylori-infected and noninfected children. Clin Diagn Lab Immunol (2003) 0.83
Local challenge of oral mucosa with gliadin in patients with coeliac disease. Clin Exp Immunol (2000) 0.82
Involvement of luminal bacteria, heat shock protein 60, macrophages and gammadelta T cells in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci (2000) 0.80
T-cell receptor heterogeneity of gamma delta T-cell clones from human female reproductive tissues. Immunology (1993) 0.79
Expression of T cell receptors alpha beta and gamma delta in the ileal mucosa of patients with Crohn's disease and with spondylarthropathy. Clin Exp Immunol (1992) 0.78
The protective effect of oral colitis-derived proteins in a murine model of inflammatory bowel disease is associated with an increase in gammadelta T cells in large intestinal mucosa. Int J Colorectal Dis (2010) 0.75
Expression of the gamma-delta T-cell receptor on intestinal CD8+ intraepithelial lymphocytes. Nature (1988) 4.89
Human gamma delta+ T cells respond to mycobacterial heat-shock protein. Nature (1989) 4.57
Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med (1989) 4.30
Specificity and function of T cells bearing gamma delta receptors. Immunol Today (1988) 3.93
Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes. Nature (1989) 3.49
Expression of disulfide-linked and non-disulfide-linked forms of the T cell receptor gamma/delta heterodimer in human intestinal intraepithelial lymphocytes. Eur J Immunol (1989) 2.80
The structure, function, and molecular genetics of the gamma/delta T cell receptor. Annu Rev Immunol (1989) 2.74
Lymphocyte subpopulations in the human small intestine. The findings in normal mucosa and in the mucosa of patients with adult coeliac disease. Clin Exp Immunol (1983) 2.34
Tissue localization and CD8 accessory molecule expression of T gamma delta cells in humans. J Immunol (1989) 1.96
A novel human V delta gene expressed predominantly in the Ti gamma A fraction of gamma/delta+ peripheral lymphocytes. Eur J Immunol (1988) 1.76
Proliferative responses of human intraepithelial lymphocytes to various T-cell stimuli. Gastroenterology (1989) 1.73
Subsets of CD3+ (T cell receptor alpha/beta or gamma/delta) and CD3- lymphocytes isolated from normal human gut epithelium display phenotypical features different from their counterparts in peripheral blood. Eur J Immunol (1990) 1.67
Immunology. Antigens for gamma/delta T cells. Nature (1989) 1.65
Signal transduction of gamma/delta T cell antigen receptor with a novel mitogenic anti-delta antibody. J Immunol (1988) 1.62
Thy-1+ dendritic epidermal cells express T3 antigen and the T-cell receptor gamma chain. Proc Natl Acad Sci U S A (1987) 1.48
Characterization of human peripheral lymphocytes expressing the CD3-gamma/delta complex with anti-receptor monoclonal antibodies. J Immunol (1988) 1.40
The microenvironment of coeliac disease: T cell phenotypes and expression of the T2 'T blast' antigen by small bowel lymphocytes. Clin Exp Immunol (1985) 1.39
CD1c as a target recognition structure for human T lymphocytes: analysis with peripheral blood gamma/delta cells. Eur J Immunol (1990) 1.36
Further analysis of the T cell receptor gamma/delta+ peripheral lymphocyte subset. The V delta 1 gene segment is expressed with either C alpha or C delta. J Exp Med (1990) 1.29
Gamma/delta T cells in the gut epithelium. Gut (1990) 1.27
Expression of T-cell receptors TcR1 (gamma/delta) and TcR2 (alpha/beta) in the human intestinal mucosa. Immunology (1989) 1.24
Colonic mucosal T lymphocytes in ulcerative colitis: expression of CD7 antigen in relation to MHC class II (HLA-D) antigens. Dig Dis Sci (1989) 1.05
Association between CAM 5.2 and anti-CD1a reactivity in lymph nodes and gastrointestinal tract epithelium. J Clin Pathol (1989) 0.79
cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A (1996) 16.69
The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet (1993) 6.84
Screening dyspepsia by serology to Helicobacter pylori. Lancet (1991) 6.13
Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol (1998) 5.07
Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut (1986) 4.47
Tissue extraction of DNA and RNA and analysis by the polymerase chain reaction. J Clin Pathol (1990) 3.30
The effect of anticoagulant choice on apparent total antioxidant capacity using three different methods. Ann Clin Biochem (1995) 3.10
Oesophageal achalasia in adolescent women mistaken for anorexia nervosa. BMJ (1992) 2.78
Selective depression of excitatory amino acid induced depolarizations by magnesium ions in isolated spinal cord preparations. J Physiol (1980) 2.53
Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med (1995) 2.52
Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. Gut (2009) 2.50
Patchiness and duodenal-jejunal variation of the mucosal abnormality in coeliac disease and dermatitis herpetiformis. Gut (1976) 2.40
Prospective study of thrombophlebitis and "pseudothrombophlebitis". Lancet (1980) 2.22
Stigmata of recent haemorrhage in diagnosis and prognosis of upper gastrointestinal bleeding. Br Med J (1978) 2.17
Immune response to Campylobacter pyloridis. Lancet (1985) 1.86
Gastric cancer, cytotoxin-associated gene A-positive Helicobacter pylori, and serum pepsinogens: an international study. The Eurogst Study Group. Gastroenterology (1999) 1.83
Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis. J Clin Pathol (1996) 1.81
Helicobacter pylori: host responses in peptic ulceration. Lancet (1993) 1.73
Reduction in circulating levels of CD4-positive lymphocytes in acute pancreatitis: relationship to endotoxin, interleukin 6 and disease severity. Br J Surg (1993) 1.73
The growing teratoma syndrome. Br J Urol (1991) 1.72
Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood (1996) 1.70
Simple method of assessing splenic function in coeliac disease. Clin Sci (Lond) (1981) 1.70
Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. Gastroenterology (1991) 1.62
Coeliac disease: a cause of various associated diseases? Lancet (1975) 1.53
The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter pylori infection. Am J Gastroenterol (2000) 1.52
Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J Clin Pathol (1998) 1.51
Helicobacter pylori and gastric inflammation. Br Med Bull (1998) 1.49
Vitamin status in treated patients with cystic fibrosis. Arch Dis Child (1981) 1.45
Increased incidence of malignancy in dermatitis herpetiformis. Br Med J (Clin Res Ed) (1983) 1.45
Cytomegalovirus infection in gastrointestinal tracts of patients infected with HIV-1 or AIDS. J Clin Pathol (1989) 1.41
Gluten sensitivity of small intestinal mucosa in vitro: quantitative assessment of histologic change. Gastroenterology (1981) 1.41
Radio-opaque pellets as faecal markers for faecal fat estimation in malabsorption. Gut (1979) 1.40
Is a raised intraepithelial lymphocyte count with normal duodenal villous architecture clinically relevant? J Clin Pathol (2002) 1.39
The microenvironment of coeliac disease: T cell phenotypes and expression of the T2 'T blast' antigen by small bowel lymphocytes. Clin Exp Immunol (1985) 1.39
Cell-mediated immunity to gluten fraction III in adult coeliac disease. Gut (1978) 1.39
Peroral small-intestinal biopsy: experience with the hydraulic multiple biopsy instrument in routine clinical practice. Gut (1976) 1.37
Ascorbic acid: a factor concentrated in human gastric juice. Clin Sci (Lond) (1989) 1.36
Immunoglobulin specificity of low grade B cell gastrointestinal lymphoma of mucosa-associated lymphoid tissue (MALT) type. Am J Pathol (1993) 1.36
Antagonism of excitatory amino acid-induced responses and of synaptic excitation in the isolated spinal cord of the frog. Br J Pharmacol (1979) 1.36
Properties of a panel of monoclonal antibodies which react with the human T cell antigen receptor on the leukemic line HPB-ALL and a subset of normal peripheral blood T lymphocytes. J Immunol (1986) 1.35
Nuclear restoration of cytoplasmic male sterility in sunflower is associated with the tissue-specific regulation of a novel mitochondrial gene. EMBO J (1994) 1.34
Asymptomatic neonatal colonisation by Clostridium difficile. Arch Dis Child (1984) 1.34
Detection of measles virus RNA in paraffin-embedded tissue. Lancet (1989) 1.32
Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood. Rheumatology (Oxford) (2006) 1.30
Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection. Eur J Gastroenterol Hepatol (1996) 1.30
Splenic size and function in adult coeliac disease. Br J Radiol (1980) 1.29
Super-efficient starch absorption. A risk factor for colonic neoplasia? Dig Dis Sci (1987) 1.28
Small intestinal ulceration: diagnostic difficulties in relation to coeliac disease. Gut (1983) 1.28
Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration. J Clin Pathol (1999) 1.28
Desmoplastic small round cell tumour: a review of literature and treatment options. Surg Oncol (2008) 1.27
Human factor XIII: fibrin-stabilizing factor. Prog Hemost Thromb (1980) 1.27
Secretion of gliadin antibody by coeliac jejunal mucosal biopsies cultured in vitro. Clin Exp Immunol (1986) 1.27
Evidence of high sugar intake, and low fibre and mineral intake, in the gluten-free diet. Aliment Pharmacol Ther (2010) 1.26
Why are Alzheimer patients thin? Age Ageing (1988) 1.26
Helicobacter pylori and gastric mucosal cytokines: evidence that CagA-positive strains are more virulent. Lab Invest (1995) 1.26
Expression of T-cell receptors TcR1 (gamma/delta) and TcR2 (alpha/beta) in the human intestinal mucosa. Immunology (1989) 1.24
Junctional communication of pancreatic beta cells contributes to the control of insulin secretion and glucose tolerance. J Clin Invest (2000) 1.23
Improved diagnostic accuracy of a modified oral pancreatic function test. Scand J Gastroenterol (1979) 1.23
Chemical faecal fat using single stools. Scand J Gastroenterol (1971) 1.23
Does super efficient starch absorption promote diverticular disease? Br Med J (Clin Res Ed) (1986) 1.21
Mucosal humoral immune response to Helicobacter pylori in patients with duodenitis. Dig Dis Sci (1991) 1.20
Contribution of the MHC region to the familial risk of coeliac disease. J Med Genet (1999) 1.20
Are all gliadins toxic in coeliac disease? An in vitro study of alpha, beta, gamma, and w gliadins. Scand J Gastroenterol (1984) 1.20
Development of enzyme linked immunosorbent assay (ELISA) to detect antibodies to Pseudomonas aeruginosa cell surface antigens in sera of patients with cystic fibrosis. J Clin Pathol (1986) 1.19
Helicobacter pylori-stimulated EGF receptor transactivation requires metalloprotease cleavage of HB-EGF. Biochem Biophys Res Commun (2002) 1.19
Small bowel malignancy in coeliac disease. Gut (2004) 1.18
Acute arthritis associated with Clostridium difficile colitis. Br Med J (Clin Res Ed) (1981) 1.18
Evidence of vitamin E deficiency in patients with malabsorption or alcoholism and the effects of therapy. Gut (1967) 1.17
Clinical relevance of an unfused pancreatic duct system. Gut (1979) 1.17
Different pathways of human T-cell activation revealed by PHA-P and PHA-M. Immunology (1986) 1.16
Opioid peptides and primary biliary cirrhosis. BMJ (1988) 1.16
ELISA for measurement of secretory IgA distinct from monomeric IgA. J Immunol Methods (1987) 1.16
Linkage analysis of candidate regions for coeliac disease genes. Hum Mol Genet (1997) 1.15
Histocompatibility antigens in chronic liver disease. Gastroenterology (1977) 1.15
Plasma and urinary zinc in patients with malabsorption syndromes or hepatic cirrhosis. Gut (1973) 1.14
Influence of laparoscopic and conventional cholecystectomy upon cell-mediated immunity. Br J Surg (1995) 1.13
CagA seropositivity associated with development of gastric cancer in a Japanese population. J Clin Pathol (1998) 1.12
Biopsy pathology of acquired immune deficiency syndrome (AIDS). J Clin Pathol (1987) 1.12
Intake and absorption of tocopherol. Ann N Y Acad Sci (1972) 1.12
Multiple genes in the left half of the cag pathogenicity island of Helicobacter pylori are required for tyrosine kinase-dependent transcription of interleukin-8 in gastric epithelial cells. Infect Immun (1999) 1.11
Review article: management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther (1996) 1.11
Hyposplenism, adult coeliac disease, and autoimmunity. Gut (1981) 1.11
The distribution of erythroblast iron in sideroblastic anaemias. Br J Haematol (1966) 1.11
Neurologic complications of liver transplantation in adults. Neurology (2003) 1.10
Cell-mediated immunity to gluten within the small intestinal mucosa in coeliac disease. Gut (1982) 1.09
Bacterial factors and immune pathogenesis in Helicobacter pylori infection. Gut (1998) 1.08
Consequences of impaired splenic function. Clin Sci (Lond) (1979) 1.08